Newsroom

Sorted by: Latest

-

Mosaic Therapeutics nomme Allison Jeynes au poste de présidente du conseil d’administration

CAMBRIDGE, Angleterre--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd (« Mosaic » ou « la société »), une société spécialisée dans les traitements oncologiques qui développe des associations médicamenteuses ciblées innovantes pour traiter divers cancers hématologiques et solides, a annoncé aujourd’hui la nomination d’Allison Jeynes au poste de présidente du conseil d’administration afin de soutenir sa prochaine phase de croissance et son avancée vers le développement clinique. Allison succède à Edwa...
-

ColdTrack Expands Fulfillment Footprint with Brand New Southeast Facility in Jacksonville, Florida

EDISON, N.J.--(BUSINESS WIRE)--ColdTrack expands its fulfillment footprint with a brand new Southeast facility in Jacksonville, Florida....
-

Deutsche Bank AG UK Regulatory Announcement: Value per Security

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 04 August 2026 COMPANY ANNOUNCEMENT Immediate Release 04 August 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 03 August 2026 Series ISIN Currency Value per Security Se...
-

PHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR)

NEW YORK--(BUSINESS WIRE)--A 22% single-session drop hit Pharming Group (PHAR) shares today after the Company reported Q2 2026 revenue of $90.2 million -- a 3% year-over-year decline against analyst consensus of roughly $419 million for the full year. If you lost money on PHAR, click here to submit your losses for review. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.The miss came from the Company's legacy product. RUCONEST sales...
-

Mosaic Therapeutics ernennt Dr. Allison Jeynes zur Vorstandsvorsitzenden

CAMBRIDGE, England--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd. („Mosaic“ oder „das Unternehmen“), ein Unternehmen für onkologische Therapeutika, das neuartige, zielgerichtete Wirkstoffkombinationen für eine Reihe von hämatologischen und soliden Krebserkrankungen entwickelt, gab heute die Ernennung von Dr. Allison Jeynes zur Vorstandsvorsitzenden bekannt, um die nächste Wachstumsphase und den Fortschritt in Richtung klinischer Entwicklung zu unterstützen. Allison tritt die Nachfolge von Dr. Edwa...
-

Fujifilm Launches FUJIFILM PROJECTOR ZUH12000

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Optical Devices Division, announces the launch of “FUJIFILM PROJECTOR ZUH12000” (FP‑ZUH12000), an interchangeable‑lens projector that supports high‑definition 4K projection and delivers a maximum brightness of 12,000 lumens. FP‑ZUH12000 will be available beginning August 6, 2026. Three optional lenses, including the industry’s only1 ultra-short-throw lens with a folded-type rotatable mechanism (FP-ZL034), will also be released...
-

Marcus & Millichap’s Institutional Property Advisors Division Brokers $90.5 Million Sale of 400 Multifamily Units in West Palm Beach

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Marcus & Millichap’s Institutional Property Advisors Division Brokers $90.5 Million Sale of 400 Multifamily Units in West Palm Beach...
-

BREAKING: Neo7Bioscience & McCullough Foundation Expose 3.5-Year Spike Persistence, Cancer Genomic Integration & mRNA Gene Chaos — Personalized Precision Peptides Restore Critically Injured Patients

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neo7Bioscience, a leader in aHI-driven personalized molecular solutions, today announced compelling evidence of prolonged SARS-CoV-2 Spike protein persistence from COVID-19 infection and mRNA vaccinations, linked to genomic instability, integration events, aggressive cancers, disabilities, and multi-system injuries. This work represents a formal research collaboration between Neo7Bioscience and Dr. Peter A. McCullough, M.D., M.P.H., Nicolas Hulscher,...
-

Sand Grove Capital Management LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mu...
-

Pacific Life Introduces New Era for Last Survivor Indexed Universal Life Insurance

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Pacific Life Insurance Company announced today the launch of Pacific Horizon Survivorship IUL 2,1 a next-generation survivorship indexed universal life insurance product built for a rapidly evolving legacy-planning landscape.2 It replaces Pacific Horizon Survivorship IUL and offers even more customized coverage than its top-ranking predecessor.“Survivorship life insurance has always played a pivotal role in financial protection and estate liquidity, but co...